Serum amyloid A2 (SAA2), alpha-1-acid-glycoprotein 2 (Orm2), and serine protease inhibitor superfamily member SERPINA1E have been proposed as biomarkers of gender-dependent carcinogenesis in HCC. This evidence concerns the gene SAA2 and hepatocellular carcinoma.